Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components
This study underscores the significant economic burden of TB in Iran, encompassing both pre-diagnosis and post-diagnosis expenses, with direct medical costs representing the largest component. Effective healthcare strategies and comprehensive public health approaches are crucial to reducing these costs and improving patient outcomes.
Authors
- Saeid Sharafi (ORCID: https://orcid.org/0000-0002-6875-3426)
- Ali Akbar Fazaeli (ORCID: https://orcid.org/0000-0002-6667-0344)
- Mahshid Nasehi (ORCID: https://orcid.org/0000-0002-2913-4294)
- Rajabali Daroudi (ORCID: https://orcid.org/0000-0002-0487-4114)
- Masoud Arefnezhad (ORCID: https://orcid.org/0000-0002-1422-8909)
Institutions
- Iran University of Medical Sciences (IR)
- Ministry of Health and Medical Education (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Research in Health Sciences
- Published
- 2025-09-15
- DOI
- https://doi.org/10.34172/jrhs.11215
- Primary Topic
- Diverse Scientific Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tehran University of Medical Sciences and Health Services